An interesting new piece of evidence recently came to light at a trial against Pfizer in Philadelphia. Internal memos suggest that Pfizer actually believed that Zoloft caused birth defects in pregnant women for years, perhaps providing the smoking gun that was missing in previous Zoloft cases.
The News
A jury in Philadelphia, PA is currently listening to evidence in a trial against Pfizer brought by the family of an 8-year-old girl, who was born with heart defects. The family’s suit alleged that Pfizer failed to adequately warn women that their antidepressant, Zoloft, might lead to birth defects. The 8-year-old girl in this case was born with congenital defects and malformations in her heart, which were allegedly caused by exposure to the drug Zoloft. In their lawsuit, the family specifically notes that the girl was born with a hole in her heart and has experienced several cardiac episodes over the years.
As part of their case, the plaintiff’s family identified internal reports by Francesca Kolitsopoulous, who is the associate director of Pfizer’s Worldwide Strategy epidemiology group. According to the evidence presented at trial, she specifically warned Pfizer executives about studies showing a link between Zoloft and heart defects.
The report suggests that she even recommended that the drug’s label be modified to warn users of this new information. Kolitsopoulous pinpointed a link between the drug and septal heart defects. This nugget of information is incredibly relevant to this case, given that it is the exact type of injury suffered by the plaintiff.